Haemonetics Corp. (HAE) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $107.60 +1.28%
Revenue Growth %: +5.5%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VFS, More
Revenue Growth %: +5.5%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VFS, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q1 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $224.49 million versus the consensus estimate of $215.85 million.
For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- Goldman Sachs Upgrades RENK Group AG (R3NK:GR) to Buy
- Baird Upgrades Regions Financial (RF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
